CIBC World Market’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-11,939
Closed -$1.17M 1435
2021
Q1
$1.17M Buy
11,939
+3,272
+38% +$298K ﹤0.01% 733
2020
Q4
$668K Buy
8,667
+4,765
+122% +$369K ﹤0.01% 862
2020
Q3
$287K Buy
+3,902
New +$313K ﹤0.01% 975
2014
Q2
Sell
-42,022
Closed -$1.58M 744
2014
Q1
$1.58M Buy
42,022
+5,398
+15% +$189K 0.01% 309
2013
Q4
$1.38M Sell
36,624
-21,602
-37% -$827K 0.01% 318
2013
Q3
$2.53M Buy
58,226
+6,048
+12% +$243K 0.01% 198
2013
Q2
$1.89M Buy
+52,178
New +$1.59M 0.01% 220

Other funds holding USNA

CIBC World Market's USNA Position: Q2 2021 in Review

CIBC World Market sold out of Usana Health Sciences (USNA) in Q2 2021, closing a stake of 11,939 shares — an estimated $1.17M sold.

CIBC World Market first reported a position in USNA in Q2 2013 and held it in 7 quarters. The position peaked at $2.53M in Q3 2013. 188 funds tracked by Wall St. Rank hold USNA as of Q2 2021.

  • CIBC World Market reported no remaining Usana Health Sciences position as of Q2 2021 after selling out during the quarter.
  • CIBC World Market sold 11,939 Usana Health Sciences shares in Q2 2021, an estimated $1.17M.
  • CIBC World Market first reported a position in Usana Health Sciences in Q2 2013 and held it in 7 quarters.
  • CIBC World Market's Usana Health Sciences position peaked at $2.53M in Q3 2013.
  • 188 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2021.

Based on CIBC World Market's 13F filing for Q2 2021, filed 12 Aug 2021.